NO20031807D0 - Fremgangsmåter for identifisering av forbindelser fra regulering av muskelmasse eller funksjon ved anvendelse av vasoaktivetarmpeptidreseptorer - Google Patents
Fremgangsmåter for identifisering av forbindelser fra regulering av muskelmasse eller funksjon ved anvendelse av vasoaktivetarmpeptidreseptorerInfo
- Publication number
- NO20031807D0 NO20031807D0 NO20031807A NO20031807A NO20031807D0 NO 20031807 D0 NO20031807 D0 NO 20031807D0 NO 20031807 A NO20031807 A NO 20031807A NO 20031807 A NO20031807 A NO 20031807A NO 20031807 D0 NO20031807 D0 NO 20031807D0
- Authority
- NO
- Norway
- Prior art keywords
- methods
- function
- muscle mass
- identifying compounds
- vasoactive intestinal
- Prior art date
Links
- 102000012088 Vasoactive Intestinal Peptide Receptors Human genes 0.000 title 1
- 108010075974 Vasoactive Intestinal Peptide Receptors Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 210000003205 muscle Anatomy 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5061—Muscle cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2235—Secretins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2869—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/5757—Vasoactive intestinal peptide [VIP] or related peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Endocrinology (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Vascular Medicine (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/694,519 US6750194B1 (en) | 2000-10-23 | 2000-10-23 | Methods of identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors |
PCT/US2001/043882 WO2002035240A2 (en) | 2000-10-23 | 2001-10-22 | Methods for identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20031807D0 true NO20031807D0 (no) | 2003-04-23 |
NO20031807L NO20031807L (no) | 2003-05-27 |
Family
ID=24789156
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20031807A NO20031807L (no) | 2000-10-23 | 2003-04-23 | Fremgangsmåter for identifisering av forbindelser fra regulering av muskelmasse eller funksjon ved anvendelse av vasoaktivetarmpeptidreseptorer |
Country Status (11)
Country | Link |
---|---|
US (2) | US6750194B1 (no) |
EP (1) | EP1358485A2 (no) |
JP (1) | JP2004512530A (no) |
AR (1) | AR031149A1 (no) |
AU (2) | AU3046602A (no) |
CA (1) | CA2426779A1 (no) |
IL (1) | IL155062A0 (no) |
NO (1) | NO20031807L (no) |
NZ (1) | NZ524693A (no) |
PE (1) | PE20020515A1 (no) |
WO (1) | WO2002035240A2 (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4487054B2 (ja) * | 1998-12-17 | 2010-06-23 | バイオフィリア研究所有限会社 | 下肢機能訓練装置 |
JP2002189809A (ja) * | 2000-12-21 | 2002-07-05 | Kyoukosan Kk | 機能回復及び筋力強化運動実施管理方法 |
US20030118585A1 (en) * | 2001-10-17 | 2003-06-26 | Agy Therapeutics | Use of protein biomolecular targets in the treatment and visualization of brain tumors |
US20060165679A1 (en) * | 2002-05-08 | 2006-07-27 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with vasoactive intestinal peptide receptor 2 (vpac2) |
AU2003204745A1 (en) * | 2002-06-17 | 2004-01-15 | Shigeo Takizawa | Rehabilitation device |
BR0314619A (pt) * | 2002-09-18 | 2005-08-02 | Univ Montreal Ct Hospitalier Chum | Análogos de ghrh |
EP1794314A2 (en) * | 2004-07-23 | 2007-06-13 | Bayer HealthCare AG | Diagnostics and therapeutics for diseases associated with vasoactive intestinal peptide receptor 1 (vpac1) |
US20080269121A1 (en) * | 2005-02-25 | 2008-10-30 | The Board Of Regents Of The University Of Texas System | Methods and Compositions Involving A1c Subunit of L-Type Calcium Channels in Smooth Muscle Cells |
WO2008036422A2 (en) * | 2006-09-22 | 2008-03-27 | Exelixis, Inc. | Vipr1s as modifiers of the e2f/rb pathway and methods of use |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4835252A (en) * | 1987-02-26 | 1989-05-30 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Vasoactive intestinal peptide analogs |
GB9318105D0 (en) | 1993-09-01 | 1993-10-20 | Medical Res Council | Receptor action |
US5831051A (en) | 1995-05-09 | 1998-11-03 | The Rockefeller University | Receptor for peptide hormones involved in energy homeostasis, and method and compositions for use thereof |
US5660824A (en) | 1995-05-24 | 1997-08-26 | Grabstein; Kenneth H. | Muscle trophic factor |
WO1998002453A2 (en) * | 1996-07-15 | 1998-01-22 | Universite Libre De Bruxelles | Peptidic ligands having a higher selectivity for the vip1 receptor than for the vip2 receptor |
US5981223A (en) | 1998-01-20 | 1999-11-09 | Smithkline Beecham Corporation | HDPXU17 encodes a novel 7-transmembrane receptor |
-
2000
- 2000-10-23 US US09/694,519 patent/US6750194B1/en not_active Expired - Fee Related
-
2001
- 2001-10-22 AU AU3046602A patent/AU3046602A/xx active Pending
- 2001-10-22 JP JP2002538172A patent/JP2004512530A/ja not_active Withdrawn
- 2001-10-22 CA CA002426779A patent/CA2426779A1/en not_active Abandoned
- 2001-10-22 WO PCT/US2001/043882 patent/WO2002035240A2/en active IP Right Grant
- 2001-10-22 NZ NZ524693A patent/NZ524693A/xx unknown
- 2001-10-22 PE PE2001001046A patent/PE20020515A1/es not_active Application Discontinuation
- 2001-10-22 AU AU2002230466A patent/AU2002230466B2/en not_active Ceased
- 2001-10-22 EP EP01988865A patent/EP1358485A2/en not_active Withdrawn
- 2001-10-22 IL IL15506201A patent/IL155062A0/xx unknown
- 2001-10-23 AR ARP010104952A patent/AR031149A1/es unknown
-
2003
- 2003-04-23 NO NO20031807A patent/NO20031807L/no not_active Application Discontinuation
-
2004
- 2004-04-23 US US10/831,393 patent/US20040176298A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US6750194B1 (en) | 2004-06-15 |
EP1358485A2 (en) | 2003-11-05 |
AR031149A1 (es) | 2003-09-10 |
AU3046602A (en) | 2002-05-06 |
IL155062A0 (en) | 2003-10-31 |
US20040176298A1 (en) | 2004-09-09 |
JP2004512530A (ja) | 2004-04-22 |
CA2426779A1 (en) | 2002-05-02 |
PE20020515A1 (es) | 2002-07-12 |
WO2002035240A3 (en) | 2003-08-21 |
NZ524693A (en) | 2006-03-31 |
AU2002230466B2 (en) | 2005-03-24 |
NO20031807L (no) | 2003-05-27 |
WO2002035240A2 (en) | 2002-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1093381T3 (da) | Antigene peptider afledt fra teleromerase | |
DK1088113T3 (da) | Fremgangsmåde til fjernelse af substanser fra faste blandinger ved elektrolyse | |
NO984898D0 (no) | FremgangsmÕte for fjerning av HCN fra syntesegass | |
ID22296A (id) | Metode untuk membersihkan gas dari hidrat-hidrat | |
NO20015411D0 (no) | Fremgangsmåte for separering av olefiner fra mettede hydrokarboner | |
NO20035504D0 (no) | Fremgangsmåte for gjenvinning av olje fra et naturlig oljereservoar | |
GB2323288B (en) | Apparatus for separating tissue from aspirates | |
GB0407598D0 (en) | Method for taking a sample from a system | |
DE69914171D1 (de) | Verfahren zum einbau von modularen schiffskabinen | |
DK1063010T3 (da) | Fremgangsmåde til fjernelse af methan fra udstödningsgasser | |
NO20031807D0 (no) | Fremgangsmåter for identifisering av forbindelser fra regulering av muskelmasse eller funksjon ved anvendelse av vasoaktivetarmpeptidreseptorer | |
DK0923300T3 (da) | Apparat til adskillelse af kød fra knogler, der omfatter kødrester | |
NO20004057L (no) | Innretning og fremgangsmÕte for separasjon av vann fra en oljeblanding som uttrekkes av en brønn | |
NO20033936D0 (no) | Fremgangsmåter for identifisering av forbindelser for regulering av muskelmasse eller funksjon ved anvendelse avkortikotropinfrigjöringsfaktorreseptorer | |
DE69726101D1 (de) | Falle zur Trennung von Abgasen | |
NO308552B1 (no) | Anordning ved avviksbor | |
NO20006568D0 (no) | Fremgangsmåte for separasjon av bestanddelene av en dispersjon | |
NO20014118D0 (no) | Fremgangsmate for fremstilling av aromatiske hydrokarboner fra C1-4-hydrokarboner | |
EP1552015A4 (en) | METHOD OF DRYING COLOR TERMINATOR SEQUENCING REAGENT | |
NO20006486D0 (no) | Fremgangsmåte for fjerning av uönskede monomere amidforbindelser fra polyamidpreparater | |
NO20003543D0 (no) | FremgangsmÕte ved fiskedeteksjon fra sonardata | |
DK39897A (da) | Fremgangsmåde til fjernelse af aromatiske forbindelser fra en carbonhydridblanding | |
EP1673153A4 (en) | PARALLEL PROCESS FOR PROTEIN OR VIRUS SEPARATION FROM A SAMPLE | |
AU2001234227A1 (en) | Method for removing sulfur compounds from gas mixtures | |
GB0009503D0 (en) | Screening method for compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |